日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Impact of the 2023/24 Influenza Vaccination on Patients with Inflammatory Rheumatic Disease in Germany: Insights from a Nationwide, Longitudinal, Self-Reported Study

2023/24年度流感疫苗接种对德国炎症性风湿病患者的影响:一项全国性纵向自我报告研究的启示

Gente, Karolina; Ditz, Benedikt; Bormann, Eike; Al-Azem, Nadine; Burmester, Gerd R; Charaf, Salma; Fräbel, Christian; Gilliam-Feld, Gabriele; Klüser, Natalie; Knothe, Anna; Müller-Ladner, Ulf; Roth, Johannes; Schulze-Koops, Hendrik; Specker, Christof; Steinmüller, Mirko; Triantafyllias, Konstantinos; Hasseli, Rebecca

Correction to: Comparative Effectiveness, Time to Discontinuation, and Patient-Reported Outcomes with Baricitinib in Rheumatoid Arthritis: 2-Year Data from the Multinational, Prospective Observational RA-BE-REAL Study in European Patients

更正:巴瑞替尼治疗类风湿性关节炎的比较疗效、停药时间和患者报告结局:来自欧洲患者的多国前瞻性观察性 RA-BE-REAL 研究的 2 年数据

Alten, Rieke; Burmester, Gerd R; Matucci-Cerinic, Marco; Salmon, Jean-Hugues; Östör, Andrew; Ng, Khai Jing; Gerwien, Jens; Zaremba-Pechmann, Liliana; Brnabic, Alan J M; Fautrel, Bruno

Rationale, Design and Methods of the Filgotinib Initial Response Study in Rheumatoid Arthritis (FIRST-RA)

菲戈替尼治疗类风湿性关节炎的初始反应研究(FIRST-RA)的原理、设计和方法

Pongratz, Georg; Alten, Rieke; Witte, Torsten; Pausch, Christine; Reinhold, Robert; Pittrow, David; Burmester, Gerd R

Benefit-risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease

在患有类风湿性关节炎且心血管疾病风险较高或较低的患者中,比较upadacitinib与adalimumab的获益风险分析

Burmester, Gerd R; Mysler, Eduardo; Taylor, Peter; Hall, Stephen; Wick-Urban, Bettina; Garrison, Andrew; Gao, Tianming; Fish, Irina; Strengholt, Sander; Fleischmann, Roy

To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI)

利用荧光光学成像(FOI)优化手部风湿性疾病的诊断过程

Stumper, Nele; Berger, Jörn; Klotsche, Jens; Gedat, Egbert; Hoff, Paula; Schmittat, Gabriela; Burmester, Gerd R; Krönke, Gerhard; Backhaus, Marina; Haugen, Ida K; Ohrndorf, Sarah

Rheumatoid factors revisited in the age of biologic therapy

生物疗法时代类风湿因子再探

Avci, Ali Berkant; Feist, Eugen; Burmester, Gerd R

Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease

乌帕替尼的安全性概况:对超过27,000患者年的数据进行描述性分析,涵盖类风湿性关节炎、银屑病关节炎、中轴型脊柱关节炎、特应性皮炎和炎症性肠病

Burmester, Gerd R; Deodhar, Atul; Irvine, Alan D; Panaccione, Remo; Winthrop, Kevin L; Vleugels, Ruth Ann; Levy, Gweneth; Suravaram, Smitha; Palac, Hannah; Wegrzyn, Lani; Ford, Sharanya; Meerwein, Sebastian; Guttman-Yassky, Emma

Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years

对接受filgotinib治疗的中重度类风湿性关节炎患者进行长达8.3年的综合安全性分析

Burmester, Gerd R; Gottenberg, Jacques-Eric; Caporali, Roberto; Winthrop, Kevin L; Tanaka, Yoshiya; Ekoka Omoruyi, Edmund V; Rajendran, Vijay; Van Hoek, Paul; Van Beneden, Katrien; Takeuchi, Tsutomu; Westhovens, René; Aletaha, Daniel

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

欧洲抗风湿病联盟(EULAR)关于银屑病关节炎药物治疗的建议:2023 年更新版

Gossec, Laure; Kerschbaumer, Andreas; Ferreira, Ricardo J O; Aletaha, Daniel; Baraliakos, Xenofon; Bertheussen, Heidi; Boehncke, Wolf-Henning; Esbensen, Bente Appel; McInnes, Iain B; McGonagle, Dennis; Winthrop, Kevin L; Balanescu, Andra; Balint, Peter V; Burmester, Gerd R; Cañete, Juan D; Claudepierre, Pascal; Eder, Lihi; Hetland, Merete Lund; Iagnocco, Annamaria; Kristensen, Lars Erik; Lories, Rik; Queiro, Rubén; Mauro, Daniele; Marzo-Ortega, Helena; Mease, Philip J; Nash, Peter; Wagenaar, Wendy; Savage, Laura; Schett, Georg; Shoop-Worrall, Stephanie J W; Tanaka, Yoshiya; Van den Bosch, Filip E; van der Helm-van Mil, Annette; Zabotti, Alen; van der Heijde, Désirée; Smolen, Josef S

Factors associated with disease flare following SARS-CoV-2 vaccination in people with inflammatory rheumatic and musculoskeletal diseases: results from the physician-reported EULAR Coronavirus Vaccine (COVAX) Registry

SARS-CoV-2疫苗接种后炎症性风湿病和肌肉骨骼疾病患者病情复发的相关因素:来自医生报告的EULAR冠状病毒疫苗(COVAX)注册研究的结果

Farisogullari, Bayram; Lawson-Tovey, Saskia; Hyrich, Kimme L; Gossec, Laure; Carmona, Loreto; Strangfeld, Anja; Mateus, Elsa F; Schäfer, Martin; Rodrigues, Ana; Hachulla, Eric; Gomez-Puerta, Jose A; Mosca, Marta; Durez, Patrick; Trefond, Ludovic; Goulenok, Tiphaine; Cornalba, Martina; Stenova, Emoke; Bulina, Inita; Strakova, Eva; Zepa, Julija; Roux, Nicolas; Brocq, Olivier; Veillard, Eric; Raffeiner, Bernd; Burmester, Gerd R; Mariette, Xavier; Machado, Pedro M